1402593-77-4

Basic information

• Product Name: N-cyclopropyl-4-{6-(3-fluoro-4-methoxyphenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridin-3-yl}-2-methylbenzamid
• Synonyms: N-cyclopropyl-4-{6-(3-fluoro-4-methoxyphenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridin-3-yl}-2-methylbenzamid
• CAS NO: 1402593-77-4
• Molecular Weight: 542.533
• Mol File: 1402593-77-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-cyclopropyl-4-{6-(3-fluoro-4-methoxyphenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridin-3-yl}-2-methylbenzamid(CAS DataBase Reference)
• NIST Chemistry Reference: N-cyclopropyl-4-{6-(3-fluoro-4-methoxyphenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridin-3-yl}-2-methylbenzamid(1402593-77-4)
• EPA Substance Registry System: N-cyclopropyl-4-{6-(3-fluoro-4-methoxyphenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridin-3-yl}-2-methylbenzamid(1402593-77-4)

Safety Data

• Hazardous Substances Data: 1402593-77-4(Hazardous Substances Data)

Upstream product

• 1402595-18-9 4-(8-amino-6-bromoimidazo[1,2-a]pyridin-3-yl)-N-cyclopropyl-2-methylbenzamide 
• 1402595-16-7 6-bromo-3-iodoimidazo[1,2-a]pyridin-8-amine 
• 1351374-48-5 N-cyclopropyl-2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide 
• 676371-00-9 6-bromoimidazo-[1,2-a]pyridin-8-ylamine 
• 345965-99-3 4-bromo-N-cyclopropyl-2-methylbenzamide 
• 68837-59-2 4-bromo-2-methylbenzoic acid 
• 38875-53-5 5-bromo-pyridine-2,3-diamine 
• 1402595-17-8 4-{6-bromo-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridin-3-yl}-N-cyclopropyl-2-methylbenzamide 
• 452-11-9 3-fluoro-4-methoxyphenol 

Downstream Products

• 1402594-63-1 N-cyclopropyl-4-{6-(3-fluoro-4-hydroxyphenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridin-3-yl}-2-methylbenzamide 

Relevant articles and documents

SUBSTITUTED IMIDAZOPYRIDINES AND INTERMEDIATES THEREOF

The present invention relates to substituted imidazopyridine compounds of general formula (I) in which R3, R5 and A are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.